Kalshi launches ‘perps’ for gold and silver following CFTC approval, expanding futures offerings

The CFTC approved Kalshi's perpetual futures tied to gold and silver, and the contracts launched Thursday, marking the first approved non-crypto perpetuals in the U.S. Kalshi's crypto perps have generated $44 billion of notional volume since their late-May launch, while its commodity event contracts surpassed $400 million in volume over seven months. The expansion raises competitive risks for established futures exchanges: CBOE and CME Group shares fell after the launch, and CME has sued the CFTC to challenge the agency's approval of U.S. perpetual futures.

Analysis

The market is likely overstating near-term fee displacement at CME. Metals futures liquidity is an ecosystem moat: hedgers require deep order books, transparent basis, portfolio margining, block liquidity, and established clearing-member credit lines—not simply a perpetual price feed. Initial volume can be highly leveraged, retail-skewed notional that generates materially less durable revenue per dollar traded than institutional futures activity; the relevant datapoint is sustained open interest, bid/ask depth during stress, and migration of commercial hedging flow over the next 6-12 months.

CME's vulnerability is more strategic than immediate: a regulated perpetual format could lower the barrier to entry for 24/7 trading and pressure exchange pricing if it is eventually extended to equities, FX, and rates. That threat is greatest in 6-18 months if competitors gain cross-margining capability and FCM distribution; absent those features, perps are more likely incremental speculative demand than direct substitution. CBOE has less direct metals exposure, making any equal-sized derating in CBOE harder to justify fundamentally and more indicative of sector-wide regulatory-disruption fear.

The key 1-3 month catalyst is litigation or regulatory clarification, not early trading-volume headlines. A court action that restricts the approval process would remove a meaningful tail risk; conversely, evidence of persistent metals open interest combined with narrow spreads and institutional onboarding would force a reassessment of CME's long-run transaction-fee and market-data multiple. The contrarian view is that regulated perps may expand the addressable derivatives market while CME retains the high-value hedging and benchmark-settlement layer.

Key Decisions for Investors

• Buy CME on further regulatory-driven weakness, preferably only after confirming that the selloff exceeds the relative move in broad financial-exchange peers. Target a 3-6 month mean reversion as the market differentiates speculative notional from commercial futures migration; invalidate if CME signals metals-volume or pricing pressure in its next earnings call, or if the legal challenge is dismissed and Kalshi reports sustained open interest rather than cumulative notional.
• Pair trade: long CBOE / short CME for a 1-3 month horizon only if regulatory momentum broadens toward equity-index or options-like perpetuals. CBOE should be relatively insulated from precious-metals substitution, while CME carries greater headline and long-duration competitive exposure; close if CME's legal action produces an injunction or if Kalshi metals liquidity fails to build after the first full month.
• Do not extrapolate platform-reported crypto notional into exchange revenue risk. Set an alert for independently verifiable metrics—daily metals open interest, average quoted spread versus COMEX, clearing-member participation, and margin offsets—before increasing any structural underweight in CME.
• For portfolios requiring downside hedging, consider a limited-risk CME put spread dated 3-6 months out rather than an outright short: the adverse case is regulatory validation plus credible institutional distribution, but CME's diversified clearing, market-data, and interest-income streams limit the probability of a sustained near-term earnings impairment.